Your browser doesn't support javascript.
loading
An Immune-Related Gene Signature Predicting Prognosis and Immunotherapy Response in Hepatocellular Carcinoma.
Zhang, Feng; Cai, Jialiang; Hu, Keshu; Liu, Wenfeng; Lu, Shenxin; Tang, Bei; Li, Miao; Wu, Weizhong; Ren, Zhenggang; Yin, Xin.
Afiliação
  • Zhang F; Liver Cancer Institute & Zhongshan Hospital, Fudan University, Shanghai, China.
  • Cai J; Liver Cancer Institute & Zhongshan Hospital, Fudan University, Shanghai, China.
  • Hu K; Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Changsha 410078, China.
  • Liu W; Liver Cancer Institute & Zhongshan Hospital, Fudan University, Shanghai, China.
  • Lu S; Liver Cancer Institute & Zhongshan Hospital, Fudan University, Shanghai, China.
  • Tang B; Liver Cancer Institute & Zhongshan Hospital, Fudan University, Shanghai, China.
  • Li M; Liver Cancer Institute & Zhongshan Hospital, Fudan University, Shanghai, China.
  • Wu W; Liver Cancer Institute & Zhongshan Hospital, Fudan University, Shanghai, China.
  • Ren Z; Liver Cancer Institute & Zhongshan Hospital, Fudan University, Shanghai, China.
  • Yin X; Liver Cancer Institute & Zhongshan Hospital, Fudan University, Shanghai, China.
Comb Chem High Throughput Screen ; 25(13): 2203-2216, 2022.
Article em En | MEDLINE | ID: mdl-35249477
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article